This product offers a CRISPR/Cas9-edited polyclonal knockout cell population of NCI-H1975 cells with targeted disruption of the IPO4 gene, encoding importin-4. The polyclonal pool provides a genetically diverse loss-of-function model, reflecting the average effect of IPO4 ablation across a mixed cellular background, without monoclonal purification. This format enables robust assessment of gene function while preserving population-level variation that may mimic tumor heterogeneity.
The NCI-H1975 host cell line is a human lung adenocarcinoma epithelial model derived from a female patient, characterized by the oncogenic EGFR L858R/T790M double mutation, which confers resistance to first-generation tyrosine kinase inhibitors. This non-small cell lung cancer line is widely employed to study EGFR-driven signaling, acquired drug resistance, and tumor cell biology. Its EGFR mutations make it particularly relevant for investigating nucleocytoplasmic transport processes that may influence proliferation and survival.
Importin-4 functions as a nuclear transport receptor that mediates the import of ribosomal proteins, histones, and other NLS-containing cargos. Mechanistically, IPO4 binds these cargos in the cytoplasm, translocates through the nuclear pore complex via interactions with importin beta and nucleoporins such as Nup153, Nup50, and Nup62, and releases them upon binding to RanGTP in the nucleus. This process is regulated by the Ran GTPase cycle components RCC1 and RanGAP, and is influenced by transcription factors including MYC and E2F. IPO4 thereby couples nucleocytoplasmic transport to ribosome biogenesis, cell cycle progression, and chromatin assembly.
In the context of NCI-H1975 cells, IPO4 knockout disrupts the nuclear import of key ribosomal and histone proteins, potentially impairing ribosome assembly and histone supply, which can lead to cell cycle defects and altered growth dynamics. Given the EGFR-mutant background, loss of IPO4 may synergize with or attenuate oncogenic signals, offering insights into how nuclear transport pathways intersect with lung adenocarcinoma pathogenesis and drug resistance mechanisms. This model is thus valuable for dissecting the role of importin-dependent transport in cancer cell fitness.
Researchers can utilize these polyclonal knockout cells in a wide range of assays. Western blotting and immunofluorescence enable detection of IPO4 and cargo mislocalization, while nuclear-cytoplasmic fractionation and co-immunoprecipitation dissect import complexes. Flow cytometry allows cell cycle distribution analysis, and proliferation or viability assays assess growth phenotypes. RNA-seq provides transcriptomic profiling under loss-of-function, and fluorescence-based nuclear import assays directly measure transport efficiency. For further product information or technical support, please contact Ascent Research.
